“This product is a breakthrough because of its proven results to improve overall health. It’s like the discovery of a new vitamin – it’s unique, affordable and easy, prompting an increase in sales worldwide.”
– Jolyon Burton
President and Head of Investment Banking, Bloom Burton & Co.
News & Media
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 202
Ottawa, ON /Business Wire/ June 6, 2023/ Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing
Avivagen Announces Significant Increase in Sales to an Existing Customer
Ottawa, ON /Business Wire/ May 25, 2023 /Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on
Avivagen Announces Review of Strategic Alternatives
Ottawa, ON /Business Wire/ May 18, 2023 /Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on
Avivagen is developing and commercializing products
that promote health in animals and humans.
Avivagen offers its commercial partners scientifically backed, evidence-based products which are in high demand from multiple channels including veterinarians, farmers and producers, pet owners and retailers.
Avivagen maintains the highest manufacturing standards and is a proud member of the NASC, a self-regulating body, which protects and enhances the integrity of the animal health product industry.
Avivagen is actively collaborating with companies in Canada, the United States, the Philippines, Korea, Vietnam, and Thailand, and we are seeking more relationships internationally.
